Skip to main content
. Author manuscript; available in PMC: 2020 Sep 16.
Published in final edited form as: Breast Cancer Res Treat. 2018 Dec 12;174(2):315–324. doi: 10.1007/s10549-018-05084-w

Table 4.

Results of the univariate and multivariable analyses for associations between clinical characteristics and probability of occult cancer

Variable Univariate
Multivariable
OR (95% CI) p OR (95% CI) p

Institution   0.50    
 LAC + USC 1.00   Excluded from the model  
 Norris 0.85 (0.54, 1.36)      
Race/ethnicity   0.58a    
 Hispanic 1.00   Excluded from the model  
 Asian 0.75 (0.36, 1.58)      
 Caucasian 1.15 (0.69, 1.90)      
 African American 0.99 (0.41, 2.42)      
 Others/unknown 0.34 (0.045.2.51)      
Age at diagnosis (years)   0.68b    
 <40 1.00   Excluded from the model  
 40-49 1.43 (0.62, 3.29)      
 50-64 1.48 (0.68, 3.22)      
 ≥65 1.23 (0.49, 3.09)      
BMI   0.16b    
 0-18.5 Small sample size   Excluded from the model  
 18.6-25 1.00      
 26-30 1.66 (0.91, 3.05)      
 ≥31 1.13(0.60, 2.13)      
 Unknown        
Biomarkers   0.040a   .062a
 HER2-, ER or PR+ 1.00   1.00  
 Triple negative 0.42(0.18, 1.01)   0.38 (0.16, 0.90)  
 HER2+ 0.71 (0.39, 1.31)   0.65 (0.35, 1.20)  
 HER2 missing 0.44 (0.20 0.98)   1.19(0.45, 3.16)  
Mammogram density   0.670    
 Fatty/scattered fibroglandular 1.00   Excluded from the model  
 Heterogeneously dense/extremely dense 1.10(0.70, 1.74)      
 Unknown        
Index lesion histology   0.008a    
 Invasive ductal/ductal carcinoma 1.00   Excluded from the model  
 Invasive lobular 1.13 (0.62, 2.07)      
 DCIS/LCIS 0.33 (0.14, 0.77)      
Index lesion grade   0.27b    
 1 1.00   Excluded from the model  
 2 0.88 (0.49, 1.58)      
 3 0.72 (0.39, 1.32)      
 Unknown        
Clinical stage   0.004b   .002b
 0 0.24(0.056, 1.06)   0.19(0.036, 1.01)  
 I 1.00   1.00  
 II 1.88(1.07, 3.30)   2.06(1.17, 3.64)  
 III 1.46 (0.74, 2.89)   1.69 (0.84, 3.38)  
 Unknown        

OR odds ratio, CI confidence interval

a

Overall p-value

b

Trend test p-value